156 related articles for article (PubMed ID: 3110175)
21. Human macrophage-activating factors for cytotoxicity. I. Establishment of a human T-cell hybridoma that produces macrophage-activating factors for cytotoxicity.
Higuchi M; Sugimoto M; Kobayashi Y; Osawa T
Microbiol Immunol; 1987; 31(5):469-79. PubMed ID: 3116371
[TBL] [Abstract][Full Text] [Related]
22. Regulation of murine macrophage function by IL-4: IL-4 and IFN-gamma differentially regulate macrophage tumoricidal activation.
Suk K; Somers SD; Erickson KL
Immunology; 1993 Dec; 80(4):617-24. PubMed ID: 8307612
[TBL] [Abstract][Full Text] [Related]
23. Taxol provides a second signal for murine macrophage tumoricidal activity.
Manthey CL; Perera PY; Salkowski CA; Vogel SN
J Immunol; 1994 Jan; 152(2):825-31. PubMed ID: 7506736
[TBL] [Abstract][Full Text] [Related]
24. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
Fogler WE; Talmadge JE; Fidler IJ
J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
[TBL] [Abstract][Full Text] [Related]
25. Activation of C3H/HeJ macrophage tumoricidal activity and cytokine release by R-chemotype lipopolysaccharide preparations. Differential effects of IFN-gamma.
Flebbe LM; Chapes SK; Morrison DC
J Immunol; 1990 Sep; 145(5):1505-11. PubMed ID: 2117032
[TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor-alpha-dependent production of reactive nitrogen intermediates mediates IFN-gamma plus IL-2-induced murine macrophage tumoricidal activity.
Cox GW; Melillo G; Chattopadhyay U; Mullet D; Fertel RH; Varesio L
J Immunol; 1992 Nov; 149(10):3290-6. PubMed ID: 1431106
[TBL] [Abstract][Full Text] [Related]
27. Expression of a 120,000 dalton protein during tumoricidal activation in murine peritoneal macrophages.
Johnston PA; Somers SD; Hamilton TA
J Immunol; 1987 Apr; 138(8):2739-44. PubMed ID: 3104474
[TBL] [Abstract][Full Text] [Related]
28. Induction, maintenance, and reinduction of tumoricidal activity in bone marrow-derived mononuclear phagocytes by Corynebacterium parvum. Evidence for the involvement of a T cell- and interferon-gamma-independent pathway of macrophage activation.
Keller R; Keist R; Van der Meide PH; Groscurth P; Aguet M; Leist TP
J Immunol; 1987 Apr; 138(7):2366-71. PubMed ID: 3104463
[TBL] [Abstract][Full Text] [Related]
29. Lack of binding of bacterial lipopolysaccharide to mouse lung macrophages and restoration of binding by gamma interferon.
Akagawa KS; Tokunaga T
J Exp Med; 1985 Nov; 162(5):1444-59. PubMed ID: 2414387
[TBL] [Abstract][Full Text] [Related]
30. A single exogenous stimulus activates resident rat macrophages for nitric oxide production and tumor cytotoxicity.
Lavnikova N; Drapier JC; Laskin DL
J Leukoc Biol; 1993 Oct; 54(4):322-8. PubMed ID: 8409754
[TBL] [Abstract][Full Text] [Related]
31. Modulation of macrophage function by gamma-irradiation. Acquisition of the primed cell intermediate stage of the macrophage tumoricidal activation pathway.
Lambert LE; Paulnock DM
J Immunol; 1987 Oct; 139(8):2834-41. PubMed ID: 3116096
[TBL] [Abstract][Full Text] [Related]
32. IL-4 inhibits the costimulatory activity of IL-2 or picolinic acid but not of lipopolysaccharide on IFN-gamma-treated macrophages.
Cox GW; Chattopadhyay U; Oppenheim JJ; Varesio L
J Immunol; 1991 Dec; 147(11):3809-14. PubMed ID: 1940368
[TBL] [Abstract][Full Text] [Related]
33. Direct activation of murine peritoneal macrophages for nitric oxide production and tumor cell killing by interferon-gamma.
Dileepan KN; Page JC; Li Y; Stechschulte DJ
J Interferon Cytokine Res; 1995 May; 15(5):387-94. PubMed ID: 7648440
[TBL] [Abstract][Full Text] [Related]
34. Protein tyrosine kinase inhibitors decrease induction of nitric oxide synthase activity in lipopolysaccharide-responsive and lipopolysaccharide-nonresponsive murine macrophages.
Dong Z; Qi X; Xie K; Fidler IJ
J Immunol; 1993 Sep; 151(5):2717-24. PubMed ID: 7689614
[TBL] [Abstract][Full Text] [Related]
35. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
Howard AD; Erickson KL
Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340
[TBL] [Abstract][Full Text] [Related]
36. Potential requirement of a functional double-stranded RNA-dependent protein kinase (PKR) for the tumoricidal activation of macrophages by lipopolysaccharide or IFN-alpha beta, but not IFN-gamma.
Gusella GL; Musso T; Rottschafer SE; Pulkki K; Varesio L
J Immunol; 1995 Jan; 154(1):345-54. PubMed ID: 7995954
[TBL] [Abstract][Full Text] [Related]
37. Role of protein kinase C and intracellular calcium mobilization in the induction of macrophage tumoricidal activity by interferon-gamma.
Celada A; Schreiber RD
J Immunol; 1986 Oct; 137(7):2373-9. PubMed ID: 3093574
[TBL] [Abstract][Full Text] [Related]
38. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor.
Sotomayor EM; Fu YX; Lopez-Cepero M; Herbert L; Jimenez JJ; Albarracin C; Lopez DM
J Immunol; 1991 Oct; 147(8):2816-23. PubMed ID: 1918995
[TBL] [Abstract][Full Text] [Related]
39. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.
Crawford RM; Finbloom DS; Ohara J; Paul WE; Meltzer MS
J Immunol; 1987 Jul; 139(1):135-41. PubMed ID: 3108395
[TBL] [Abstract][Full Text] [Related]
40. Recombinant IFN-gamma synergizes with lipopolysaccharide to induce macrophage membrane procoagulants.
Moon DK; Geczy CL
J Immunol; 1988 Sep; 141(5):1536-42. PubMed ID: 2457619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
